Strategy performance
NAFA Pharma Portfolio
Nafa Asset Managers Private Limited · AUM ₹0.00 Cr · as of Sep 2026
Our read
Since inception the filed path is −18.0% (−5.7% CAGR), with a max drawdown of −33.2%. Benchmark series for this window is not reported here.
Generated from the numbers below. A description, not a recommendation.
3Y CAGR
−12.3%
Since inception
−5.7%
Max drawdown
−33.2%
Volatility
+14.7%
Peer position
Loading peer ranks…
Performance
NAFA Pharma Portfolio₹82.0Sep 26
Monthly returns
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |||
| 2025 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |||||
| 2024 | — | ||||||||||||
| 2023 | 0.0% | 0.0% | 0.0% | ||||||||||
| 2022 | −8.6% | −4.9% | +3.3% | +0.3% | −7.8% | −3.6% | +5.8% | +0.5% | +0.8% | +0.9% | +1.1% | −17.2% | −27.6% |
| 2021 | +2.1% | +2.8% | +12.3% | +3.0% | +0.2% | +0.2% | +0.6% | −2.7% | −4.8% | −2.0% | +1.8% | +13.3% |
Metrics
Tearsheet- 1M return
- 0.0%
- 3M return
- 0.0%
- 6M return
- 0.0%
- 1Y return
- 0.0%
- 2Y CAGR
- −4.9%
- 3Y CAGR
- −12.3%
- 5Y CAGR
- Needs 60 months
- Since-inception CAGR
- −5.7%
- Total return
- −18.0%
- Average month
- −0.4%
- Median month
- 0.0%
- Average up month
- +2.4%
- Best month
- +12.3%
- Best rolling 12M
- +3.6%
Read from the filed snapshot (engine 1.0). A short track says how many months that window needs.
Source: SEBI monthly PMS filings, Sep 2026. Returns are TWRR, net of fees as filed. Not investment advice. How we calculate
Filings
Month-end SEBI filings. Missing months stay blank.
NAFA Pharma Portfolio performance FAQ
Live figures from the scorecard above. Full definitions on the metrics explainer.
- How has NAFA Pharma Portfolio performed?
- NAFA Pharma Portfolio (Nafa Asset Managers Private Limited) shows CAGR -5.65% and max drawdown -33.17% on Know Your PMS from SEBI month-end TWRR filings. A short window says how many months it still needs. A gap on a longer track stays Not reported. Learn more
- What is NAFA Pharma Portfolio CAGR / max drawdown?
- CAGR is -5.65%; max drawdown is -33.17%. We only publish CAGR when there are enough months (≥12 on this track of 41 months). Learn more
- Where do NAFA Pharma Portfolio returns come from?
- Returns are derived from SEBI-disclosed monthly 1M TWRR filings. Know Your PMS never invents zeros for unfiled months. Learn more
- Why might a window say Not reported?
- Trailing 1Y, 3Y, and 5Y need that many consecutive months. A short track says Needs 12 months, Needs 36 months, or Needs 60 months. A longer track with a missing month stays Not reported. Learn more
- How do I re-underwrite NAFA Pharma Portfolio?
- Read as-of and track length first. CAGR says Needs 12 months below 12 filed months. Watch for new filings, add 2–4 peers on Compare for the same as-of, then export or open the tearsheet. Not advice. Learn more
- Is this a recommendation to invest?
- No. Know Your PMS is research-only: no commissions, no execution, no advice. Use compare to shortlist 2–4 on the same as-of for your own diligence. Learn more